Development and validation of an HPLC-MS/MS analytical method for quantitative analysis of TCBA-TPQ, a novel anticancer makaluvamine analog, and application in a pharmacokinetic study in rats
13
R917(药物基础科学)
This work was supported by the National Institutes of Health NIH grants R01 CA112029,R01 CA121211,and R01 CA186662 to R.Z. and 1UL1RR025777 to S.V..The contents are solely the responsibility of the authors,and do not necessarily represent the official views of the National Institutes of Health.
2015-08-14(万方平台首次上网日期,不代表论文的发表时间)
554-560